{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:48:19Z","timestamp":1794023299307,"version":"4.8.0"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.2169\/internalmedicine.2838-19","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T22:03:32Z","timestamp":1568153012000},"page":"107-112","source":"Crossref","is-referenced-by-count":12,"title":["Long-term Survival of a Patient with Small Cell Lung Cancer Secreting ADH and ACTH Simultaneously, Following the Prolonged Use of Amrubicin"],"prefix":"10.2169","volume":"59","author":[{"given":"Aya","family":"Kosuda","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, JCHO Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Shirahata","sequence":"additional","affiliation":[{"name":"Department of Respirology, JCHO Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasa","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, JCHO Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, JCHO Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Department of Respirology, JCHO Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aika","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, and Nephrology, JCHO Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, and Nephrology, JCHO Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, JCHO Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clinic Proc 85: 838-854, 2010."},{"key":"2","unstructured":"2. Agarwal KA, Soe MH. Beyond the dual paraneoplastic syndromes of small-cell lung cancer with ADH and ACTH secretion: a case report with literature review and future implications. Case Rep Oncol Med 2018: 4038397, 2018."},{"key":"3","unstructured":"3. Isidori AM, Kaltsas GA, Pozza C, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91: 371-377, 2006."},{"key":"4","unstructured":"4. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing&apos;s syndrome due to ectopic corticotropin secretion: twenty years&apos; experience at the National Institutes of Health. J Clin Endocrinol Metab 90: 4955-4962, 2005."},{"key":"5","unstructured":"5. Ghazi AA, Abbasi Dezfooli A, Amirbaigloo A, et al. Ectopic Cushing&apos;s syndrome secondary to lung and mediastinal tumours - report from a tertiary care centre in Iran. Endokrynol Pol 66: 2-9, 2015."},{"key":"6","unstructured":"6. Suzuki H, Tsutsumi Y, Yamaguchi K, Abe K, Yokoyama T. Small cell lung carcinoma with ectopic adrenocorticotropic hormone and antidiuretic hormone syndromes: a case report. Jpn J Clin Oncol 14: 129-137, 1984."},{"key":"7","unstructured":"7. Shaker JL, Brickner RC, Divgi AB, Raff H, Findling JW. Case report: renal phosphate wasting, syndrome of inappropriate antidiuretic hormone, and ectopic corticotropin production in small cell carcinoma. Am J Med Sci 310: 38-41, 1995."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pierce ST, Metcalfe M, Banks ER, O&apos;Daniel ME, DeSimone P. Small cell carcinoma with two paraendocrine syndromes. Cancer 69: 2258-2261, 1992.","DOI":"10.1002\/1097-0142(19920501)69:9<2258::AID-CNCR2820690908>3.0.CO;2-5"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. O&apos;Neal LW, Kipnis DM, Luse SA, Lacy PE, Jarett L. Secretion of various endocrine substances by ACTH-secreting tumors--gastrin, melanotropin, norepinephrine, serotonin, parathormone, vasopressin, glucagon. Cancer 21: 1219-1232, 1968.","DOI":"10.1002\/1097-0142(196806)21:6<1219::AID-CNCR2820210625>3.0.CO;2-M"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Coscia M, Brown HD, Miller M, et al. Ectopic production of antidiuretic hormone (adh), adrenocorticotrophic hormone (ACTH) and beta-melanocyte stimulating hormone (beta-MSH) by an oat cell carcinoma of the lung. American J Med 62: 303-307, 1977.","DOI":"10.1016\/0002-9343(77)90327-8"},{"key":"11","unstructured":"11. Mayer S, Cypess AM, Kocher ON, et al. Uncommon presentations of some common malignancies: Case 1. Sequential paraneoplastic endocrine syndromes in small-cell lung cancer. J Clin Oncol 23: 1312-1314, 2005."},{"key":"12","unstructured":"12. Liddle GW, Givens JR, Nicholson WE, Island DP. The ectopic ACTH syndrome. Cancer Res 25: 1057-1061, 1965."},{"key":"13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2007.03.003","volume":"57","author":"K M\u00fcssig","year":"2007","unstructured":"13. M\u00fcssig K, Horger M, H\u00e4ring HU, Wehrmann M. Syndrome of inappropriate antidiuretic hormone secretion and ectopic ACTH production in small cell lung carcinoma. Lung Cancer 57: 120-122, 2007.","journal-title":"Lung Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"14","unstructured":"14. Hendifar AE, Marchevsky AM, Tuli R. Neuroendocrine tumors of the lung: current challenges and advances in the diagnosis and management of well-differentiated disease. J Thorac Oncol 12: 425-436, 2017."},{"key":"15","unstructured":"15. Reisinger I, Bohuslavitzki KH, Brenner W, et al. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study. J Nucl Med 39: 224-227, 1998."},{"key":"16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.lungcan.2011.09.014","volume":"76","author":"K Zarogoulidis","year":"2012","unstructured":"16. Zarogoulidis K, Eleftheriadou E, Kontakiotis T, et al. Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients. Lung Cancer 76: 84-88, 2012.","journal-title":"Lung Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lapa C, Hanscheid H, Wild V, Pelzer T, Schirbel A, Werner RA, et al. Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy. Oncotarget 7: 20033-20040, 2016.","DOI":"10.18632\/oncotarget.7706"},{"key":"18","unstructured":"18. Seshadri M, Poduval TB, Sundaram K. Studies on metastases. I. Role of sensitization and immunosuppression. J Nat Cancer Inst 63: 1205-1210, 1979."},{"key":"19","unstructured":"19. Fidler IJ, Gersten DM, Kripke ML. Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities. Cancer Res 39: 3816-3821, 1979."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sherlock P, Hartmann WH. Adrenal steroids and the pattern of metastases of breast cancer. JAMA 181: 313-317, 1962.","DOI":"10.1001\/jama.1962.03050300033007"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Iversen HG, Hjort GH. The influence of corticoid steroids on the frequency of spleen metastases in patients with breast cancer. Acta Pathol Microbiol Scand 44: 205-212, 1958.","DOI":"10.1111\/j.1699-0463.1958.tb01070.x"},{"key":"22","unstructured":"22. Mitre-Aguilar IB, Cabrera-Quintero AJ, Zentella-Dehesa A. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer. Int J Clin Exp Pathol 8: 1-10, 2015."},{"key":"23","unstructured":"23. Yana T, Negoro S, Takada M, et al. Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study. Invest New Drugs 25: 253-258, 2007."},{"key":"24","unstructured":"24. Onoda S, Masuda N, Seto T, et al. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol 24: 5448-5453, 2006."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Jotte R, Conkling P, Reynolds C, et al. Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy. J Clin Oncol 29: 287-293, 2011.","DOI":"10.1200\/JCO.2010.29.8851"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97: 2869-2879, 2003.","DOI":"10.1002\/cncr.11407"},{"key":"27","unstructured":"27. Sumitomo Chemical Industry Company, Sumitomo Dainippon Pharma. [Information about Amrubicin]. Pharmaceuticals and Medical Devices Agency [Internet]. [cited 2019 Jun 6]; Available from: http:\/\/www.pmda.go.jp\/drugs\/2002\/P200200013\/index.html (in Japanese)"},{"key":"28","unstructured":"28. Higashiguchi M, Suzuki H, Hirashima T, et al. Long-term amrubicin chemotherapy for small-cell lung cancer. Anticancer Res 32: 1423-1427, 2012."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/1\/59_2838-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T05:35:32Z","timestamp":1578288932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/1\/59_2838-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2838-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}